3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
32
Myelodysplastic Syndromes
28
Multiple Myeloma
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Hodgkin Disease
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Lymphoma, Non-Hodgkin
10
Lymphoma
10
Hematologic Neoplasms
10
Neuroblastoma
9
Myeloproliferative Disorders
9
Anemia, Refractory, with Excess of Blasts
8
Lymphoma, Mantle-Cell
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia
7
Neoplasms, Plasma Cell
6
Lymphoma, T-Cell
6
Leukemia, Biphenotypic, Acute
6
Graft vs Host Disease
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Burkitt Lymphoma
5
Recurrence
4
Primary Myelofibrosis
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Diseases
4
Ganglioneuroblastoma
4
Anemia, Aplastic
4
Interventions
Nivolumab
7
cemiplimab
6
Specimen Handling
5
HhAntag691
5
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
4
Biopsy
4
sonidegib
3
pembrolizumab
3
CTLA-4 Antigen
3
relatlimab
2
prednylidene
2
deltacortene
2
daromun
2
Surgical Procedures, Operative
2
Standard of Care
2
Prednisone
2
Observation
2
Aminolevulinic Acid
2
tocilizumab
1
talimogene laherparepvec
1
poly ICLC
1
flt3 ligand protein
1
X-Rays
1
Watchful Waiting
1
Vitamin D
1
Tomography, Optical Coherence
1
Therapeutics
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Basal Cell
×
Melphalan
×
1 year
×
Clear all
No trials found.